Intensive glucose-lowering therapy shown to have beneficial effects on kidney function in diabetics

被引：0
|
作者：
Wilkinson, Jonathan
机构：
来源：
EXPERT REVIEW OF CLINICAL IMMUNOLOGY | 2012年 / 8卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [1] Intensive glucose-lowering therapy shown to have beneficial effects on kidney function in diabetics
    Wilkinson, Jonathan
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2012, 7 (01) : 7 - 7
  • [2] Intensive glucose-lowering therapy—weighing up the evidence
    Neale Cohen
    [J]. Nature Reviews Endocrinology, 2010, 6 : 9 - 10
  • [3] The Effects of Glucose-Lowering Therapies on Diabetic Kidney Disease
    Agrawal, V.
    Giri, C.
    Solomon, R. J.
    [J]. CURRENT DIABETES REVIEWS, 2015, 11 (03) : 191 - 200
  • [4] Glucose-Lowering Effects of Imeglimin and Its Possible Beneficial Effects on Diabetic Complications
    Yanai, Hidekatsu
    Adachi, Hiroki
    Hakoshima, Mariko
    Katsuyama, Hisayuki
    [J]. BIOLOGY-BASEL, 2023, 12 (05):
  • [5] DIABETES Intensive glucose-lowering therapy-weighing up the evidence
    Cohen, Neale
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (01) : 9 - 10
  • [6] Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose-lowering therapy?
    Inzucchi, Silvio E.
    Fitchett, David
    Jurisic-Erzen, Dubravka
    Woo, Vincent
    Hantel, Stefan
    Janista, Christina
    Kaspers, Stefan
    George, Jyothis T.
    Zinman, Bernard
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (04): : 631 - 639
  • [7] Glycaemic control and glucose-lowering therapy in diabetic patients with kidney disease
    Mpondo, B.
    [J]. AFRICAN JOURNAL OF DIABETES MEDICINE, 2014, 22 (01): : 12 - 16
  • [8] Intensive glucose-lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial
    Ohkuma, Toshiaki
    Zoungas, Sophia
    Jun, Min
    Liu Lisheng
    Mancia, Giuseppe
    Marre, Michel
    Rodgers, Anthony
    Williams, Bryan
    Woodward, Mark
    Chalmers, John
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (03): : 452 - 457
  • [9] Intensive glucose-lowering arm of ACCORD trial halted
    不详
    [J]. FUTURE CARDIOLOGY, 2008, 4 (02) : 113 - 113
  • [10] Chronic Kidney Disease in Type 2 Diabetes: Optimizing Glucose-Lowering Therapy
    Bakris, George
    [J]. JOURNAL OF FAMILY PRACTICE, 2019, 68 (08): : S1 - S6
12345